Picture of Newbury Pharmaceuticals AB logo

NEWBRY — Newbury Pharmaceuticals AB News Story

0.000.00%
se flag iconLast trade - 00:00
Consumer DefensivesHighly SpeculativeMicro CapMomentum Trap

Brief: Newbury Pharmaceuticals Secures Generic Approval For Buspiron

Oct 28 (Reuters) - Newbury Pharmaceuticals AB
 NEWBRY.ST :
    * NEWBURY PHARMACEUTICALS SECURES GENERIC APPROVAL FOR
BUSPIRON
    * NEWBURY PHARMACEUTICALS AB - WILL PROCEED TO LAUNCH
PRODUCT
    * NEWBURY PHARMACEUTICALS AB - ANNUAL VALUE OF MARKET
ESTIMATED TO
BE 0,9 MEUR ACCORDING TO DLMI NORDIC PHARMA INSIGHTS

Source text:  ID:nMFN8Hl1Ps 
Further company coverage:  NEWBRY.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Newbury Pharmaceuticals AB

See all news